Medicine & Life Sciences
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide
42%
8-hydroxyefavirenz
63%
Acute Coronary Syndrome
39%
Antihypertensive Agents
25%
Aryl Hydrocarbon Receptors
100%
Athletes
17%
Biological Monitoring
20%
Biotransformation
32%
Blood Pressure
31%
Cardiotoxicity
33%
Case-Control Studies
17%
Coronary Artery Disease
16%
Cysteine
57%
Cytochrome P-450 CYP1A1
34%
Diabetic Nephropathies
20%
Disulfides
20%
efavirenz
51%
Heart Diseases
15%
HIV
13%
Hodgkin Disease
20%
Homocysteine
42%
Homocysteinemia
60%
Hypertension
47%
Hypertrophic Cardiomyopathy
44%
Hypoxia
48%
Infarction
19%
Kidney
25%
Kidney Cortex
30%
Left Ventricular Function
30%
Mediastinal Diseases
15%
Methotrexate
18%
Mitral Valve Stenosis
16%
Myocardial Infarction
35%
Non-Smokers
15%
Noncommunicable Diseases
22%
Obstructive Sleep Apnea
26%
Oxidation-Reduction
21%
Pharmacology
14%
Precision Medicine
24%
pro-brain natriuretic peptide (1-76)
25%
Pulmonary Embolism
19%
Radiation
14%
Radiotherapy
13%
Rheumatoid Arthritis
16%
Rheumatologists
15%
Smokers
16%
Stroke Volume
13%
Tertiary Care Centers
17%
Trastuzumab
23%
Vascular Diseases
18%
Chemistry
Antihypertensive
9%
Aryl Hydrocarbon Receptor Antagonist
19%
Biological Marker
5%
Biomonitoring
13%
Blood Pressure
28%
Cysteine
42%
Cystine
15%
Disulfide
16%
Drug
12%
Efavirenz
59%
Electrophile
6%
Glutathione
5%
Hydrocarbon
27%
Indicator
5%
Metabolic
9%
Metabolite
20%
Neurotoxicity
24%
Pharmacological Metabolism
9%
Plasma Concentration
15%
Protein
7%
Thiol
10%
Time
8%